11:02AM ET 8/01/2022 MT NewswiresArmata Pharmaceuticals (ARMP) said Monday the US Food and Drug Administration has cleared an Investigational New Drug Application for AP-SA02 for treatment...
10:06AM ET 5/23/2022 MT NewswiresArmata Pharmaceuticals (ARMP) said Monday it has dosed the first person in the phase 1b/2a clinical trial of AP-SA02 to treat complicated Staphylococcus...
4:15AM ET 3/30/2022 MT NewswiresArmata Pharmaceuticals (ARMP) filed a registration statement with the US Securities and Exchange Commission on behalf of certain shareholders for the...
12:00PM ET 2/22/2022 MT NewswiresArmata Pharmaceuticals (ARMP) said Tuesday the US Food and Drug Administration has cleared its investigational drug application to launch a clinical trial...